Monitoring immunity to cancer vaccines
Publication
, Other
Hobeika, AC; Clay, TM; Morse, MA
Published in: Enhancer - Biotherapy of Cancer
December 4, 2006
The potential use of vaccines to treat and prevent cancer has developed into an area of intense research. Great success has been achieved historically with vaccines against infectious agents, and observations such as a graft vs leukemia effect and spontaneous regression of tumors indicate the ability of the immune system to attack tumor cells. Vaccines are also an attractive option for cancer, because of the low level of side effects and complications compared with traditional cancer therapies. Further, vaccines can be combined with other immunomodulatory agents, such as cytokines and co-stimulatory factors, to further enhance the antitumor immune response.
Duke Scholars
Published In
Enhancer - Biotherapy of Cancer
ISSN
1572-0004
Publication Date
December 4, 2006
Volume
4
Issue
2
Start / End Page
8 / 11
Citation
APA
Chicago
ICMJE
MLA
NLM
Hobeika, A. C., Clay, T. M., & Morse, M. A. (2006). Monitoring immunity to cancer vaccines. Enhancer - Biotherapy of Cancer.
Hobeika, A. C., T. M. Clay, and M. A. Morse. “Monitoring immunity to cancer vaccines.” Enhancer - Biotherapy of Cancer, December 4, 2006.
Hobeika AC, Clay TM, Morse MA. Monitoring immunity to cancer vaccines. Vol. 4, Enhancer - Biotherapy of Cancer. 2006. p. 8–11.
Hobeika, A. C., et al. “Monitoring immunity to cancer vaccines.” Enhancer - Biotherapy of Cancer, vol. 4, no. 2, 4 Dec. 2006, pp. 8–11.
Hobeika AC, Clay TM, Morse MA. Monitoring immunity to cancer vaccines. Enhancer - Biotherapy of Cancer. 2006. p. 8–11.
Published In
Enhancer - Biotherapy of Cancer
ISSN
1572-0004
Publication Date
December 4, 2006
Volume
4
Issue
2
Start / End Page
8 / 11